Clinical Research Directory
Browse clinical research sites, groups, and studies.
MASKd: a Study on Kawasaki Disease (KD) Complicated by Macrophage Activation Syndrome (MAS)
Sponsor: Meyer Children's Hospital IRCCS
Summary
Kawasaki Disease (KD) is one of the most common vasculitides in childhood and represents a leading cause of acquired heart disease in developed countries. Macrophage Activation Syndrome (MAS) is a potentially life threatening hyperinflammatory condition belonging to the spectrum of hemophagocytic lymphohistiocytosis (HLH), and it can complicate various rheumatologic diseases. Awareness of MAS in the context of KD has recently increased, supporting the hypothesis that it is an underdiagnosed complication. The study aims to define the epidemiology, clinical characteristics, management, and therapeutic strategies of MAS in patients with KD, through a multicenter data collection in Europe.
Official title: MACROPHAGE ACTIVATION SYNDROME IN KAWASAKI DISEASE: Features, Treatment, Outcome, Predictive and Diagnostic Factors (The MASKd Study)
Key Details
Gender
All
Age Range
4 Weeks - 17 Years
Study Type
OBSERVATIONAL
Enrollment
150
Start Date
2026-02
Completion Date
2029-02
Last Updated
2026-03-25
Healthy Volunteers
No
Locations (1)
Azienda Ospedaliero-Universitaria IRCCS Meyer
Florence, Italy, Italy